|
CHIC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.76558767606139E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.64153152077051E-14 |
| Normal-vs-Stage2 |
1.964650E-03 |
| Normal-vs-Stage3 |
5.975600E-04 |
| Normal-vs-Stage4 |
6.402200E-03 |
| Stage1-vs-Stage2 |
3.511600E-01 |
| Stage1-vs-Stage3 |
1.882010E-01 |
| Stage1-vs-Stage4 |
9.463000E-01 |
| Stage2-vs-Stage3 |
8.667400E-01 |
| Stage2-vs-Stage4 |
5.482400E-01 |
| Stage3-vs-Stage4 |
4.426000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.43107747874183E-13 |
| Normal-vs-AfricanAmerican |
6.75579999720455E-08 |
| Normal-vs-Asian |
1.643350E-01 |
| Caucasian-vs-AfricanAmerican |
9.077200E-01 |
| Caucasian-vs-Asian |
6.274600E-01 |
| AfricanAmerican-vs-Asian |
6.780200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44089209850063E-16 |
| Normal-vs-Female |
6.970800E-04 |
| Male-vs-Female |
1.428290E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.74120000000699E-05 |
| Normal-vs-Extreme_Weight |
1.62503344114384E-12 |
| Normal-vs-Obese |
8.58730000441454E-08 |
| Normal-vs-Extreme_Obese |
3.297900E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.029590E-01 |
| Normal_Weight-vs-Obese |
9.584400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.474600E-01 |
| Extreme_Weight-vs-Obese |
2.525900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.485800E-01 |
| Obese-vs-Extreme_Obese |
9.108800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.41420000055304E-07 |
| Normal-vs-Age(41-60Yrs) |
1.24449994753917E-09 |
| Normal-vs-Age(61-80Yrs) |
2.00950367457153E-14 |
| Normal-vs-Age(81-100Yrs) |
6.033700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.236400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.114400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.948800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.285600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.917600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.367800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.44089209850063E-16 |
| Normal-VS-Type2 PRCC |
5.62319999999339E-05 |
| Normal-VS-KIRP CIMP |
1.7715299999943E-05 |
| Normal-VS-Unclassified PRCC |
5.629300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.092340E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.991000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.021170E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.840600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.774000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.900600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.35409999879599E-08 |
| Normal-vs-N1 |
1.275240E-03 |
| Normal-vs-N2 |
7.441500E-04 |
| N0-vs-N1 |
7.199600E-01 |
| N0-vs-N2 |
9.811800E-01 |
| N1-vs-N2 |
8.654400E-01 |
|
|
